These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20923036)

  • 1. Intensity-modulated radiation therapy for anal cancer: an obvious yet complicated transition.
    Herman JM; Thomas CR
    Oncology (Williston Park); 2010 Aug; 24(9):828, 830-1. PubMed ID: 20923036
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiotherapy for Anal Cancer: Intensity-Modulated Radiotherapy and Future Directions.
    Castaneda SA; Romak LB
    Surg Oncol Clin N Am; 2017 Jul; 26(3):467-475. PubMed ID: 28576183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiation therapy for anal cancer: toxicity versus outcomes.
    Zagar TM; Willett CG; Czito BG
    Oncology (Williston Park); 2010 Aug; 24(9):815-23, 828. PubMed ID: 20923035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RTOG 0529: Intensity modulated radiation therapy and anal cancer, a step in the right direction?
    Herman JM; Thomas CR
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):8-10. PubMed ID: 23582245
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.
    Pepek JM; Willett CG; Wu QJ; Yoo S; Clough RW; Czito BG
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1413-9. PubMed ID: 20231064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy.
    Devisetty K; Mell LK; Salama JK; Schomas DA; Miller RC; Jani AB; Roeske JC; Aydogan B; Chmura SJ
    Radiother Oncol; 2009 Nov; 93(2):298-301. PubMed ID: 19717198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
    Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiation therapy.
    Lee NY; Terezakis SA
    J Surg Oncol; 2008 Jun; 97(8):691-6. PubMed ID: 18493919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of intensity-modulated radiation therapy in anorectal cancer.
    Meyer JJ; Willett CG; Czito BG
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):585-93. PubMed ID: 18402525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer.
    Saarilahti K; Arponen P; Vaalavirta L; Tenhunen M
    Radiother Oncol; 2008 Jun; 87(3):383-90. PubMed ID: 18501454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced radiation technology in the treatment of anal cancer.
    Barriger RB; Johnstone PA
    Oncology (Williston Park); 2009 Nov; 23(12):1096, 1098. PubMed ID: 20017293
    [No Abstract]   [Full Text] [Related]  

  • 12. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
    Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
    Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ
    J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential and limitations of intensity-modulated radiotherapy in anal cancer.
    Vordermark D
    J Clin Oncol; 2008 Feb; 26(4):688; author reply 688-9. PubMed ID: 18235135
    [No Abstract]   [Full Text] [Related]  

  • 15. Anal cancer: an examination of radiotherapy strategies.
    Glynne-Jones R; Lim F
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1290-301. PubMed ID: 21414513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jury still out on whether advanced technology can improve the outcomes of patients with anal canal cancer.
    Konski A; Kachnic LA
    Oncology (Williston Park); 2009 Nov; 23(12):1092, 1094, 1096. PubMed ID: 20017292
    [No Abstract]   [Full Text] [Related]  

  • 17. Advanced radiation therapy technologies in the treatment of rectal and anal cancer: intensity-modulated photon therapy and proton therapy.
    Meyer J; Czito B; Yin FF; Willett C
    Clin Colorectal Cancer; 2007 Jan; 6(5):348-56. PubMed ID: 17311699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protons in head-and-neck cancer: bridging the gap of evidence.
    Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy in anal cancer: where do we go from here?
    Gilbert DC; Glynne-Jones R
    Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):153-4. PubMed ID: 22921809
    [No Abstract]   [Full Text] [Related]  

  • 20. Dosimetric parameters predictive of acute gastrointestinal toxicity in patients with anal carcinoma treated with concurrent chemotherapy and intensity-modulated radiation therapy.
    DeFoe SG; Kabolizadeh P; Heron DE; Beriwal S
    Oncology; 2013; 85(1):1-7. PubMed ID: 23736101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.